(Press-News.org) Reston, VA—A new 225Ac-DOTA-based pre-targeted radioimmunotherapy (PRIT) system has been shown to cure a highly lethal form of advanced intraperitoneal ovarian cancer in a preclinical setting with minimal side effects. Targeting the HER2 protein, which is commonly expressed in ovarian cancer, the therapy (anti-HER2 225Ac-PRIT) is a potential treatment for the otherwise incurable disease. This research was published in the September issue of The Journal of Nuclear Medicine.
Epithelial ovarian cancer is the most lethal ovarian cancer and frequently presents as advanced-stage disease, such as peritoneal carcinomatosis, where disease has spread throughout the peritoneal cavity. Advanced-stage disease is associated with a poor prognosis and a five-year overall survival ranging from 18 to 46 percent. Most patients die because of extensive peritoneal disease burden and malignant bowel obstruction.
“Due to the explosion of immune and targeted therapies in the past few decades—particularly those targeting HER2—there is increasing interest in the potential role of alternative, more innovative therapies to cure epithelial ovarian cancer,” said Sarah M. Cheal, PhD, of the Molecular Imaging Innovations Institute in the Department of Radiology at Weill Cornell Medical College in New York, New York. “In this study, we adapted our PRIT system to target HER2 in epithelial ovarian cancer and explored whether this could effectively treat the disease without significant toxicity.”
The preclinical study included five groups of eight to 10 nude mice, each bearing peritoneal carcinomatosis tumors. Two groups of mice were treated with either one or two cycles of anti-HER2 225Ac-PRIT; the other groups received alternative or no treatments and were used as controls. Weekly weights and tumor progression were monitored for up to 154 days.
Tumors spread rapidly in untreated mice, leading to a median survival of approximately four months. When treated with one or two cycles of anti-HER2 225Ac-PRIT, however, median survival was not reached after 154 days. At the end of the study, 75 percent of mice in the anti-HER2 225Ac-PRIT treatment groups were confirmed to be clinically cured. All treatments were well tolerated by the mice.
“In this study we achieved high potency with anti-HER2 225Ac-PRIT while maintaining an acceptable safety profile. These findings suggest that when scaled to human patients, we can achieve curative tumor radiation-absorbed doses without major normal organ toxicity” stated Steven M. Larson, MD, of the Department of Radiology at Memorial Sloan Kettering Cancer Center in New York.
“Furthermore,” stated Nai-Kong V. Cheung, MD, PhD, of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center in New York, “since DOTA-based PRIT is modular it can be adapted to other cancers and next generation PRIT using SADA (Self-Assembling DisAssembling Antibody) with potential for broad applications for compartmental (e.g. peritoneal) as well as systemic theranostics in oncology.”
This study was made available online in June 2023.
The authors of “Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis” include Sebastian K. Chung, Christopher S. Chandler, Garrett M. Nash, and Andrea Cercek, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; Daniela Burnes Vargas, Shin H. Seo, Blesida Punzalan and Mitesh Patel, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; Sumudu Katugampola and Roger W. Howell, Division of Radiation Research, Department of Radiology and Center for Cell Signaling, New Jersey Medical School, Rutgers University, Newark, New Jersey; Darren R. Veach and Michael R. McDevitt, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, and Department of Radiology, Weill Cornell Medicine, New York, New York; Brett A. Vaughn and Sarah M. Cheal, Department of Radiology, Weill Cornell Medicine, New York, New York, and Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York; Sara S. Rinne, Department of Radiology, Weill Cornell Medicine, New York, New York, and Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York; Hong Xu, Hong-Fen Guo, and Nai-Kong V, Cheung, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York; Pat B. Zanzonico, Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; Sébastien Monette, Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, and Rockefeller University, New York, New York; Guangbin Yang and Ouathek Ouerfelli, Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York; Edward K. Fung, Department of Radiology, Weill Cornell Medicine, New York, New York; and Steven M. Larson, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, Department of Radiology, Weill Cornell Medicine, New York, New York, and Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Visit the JNM website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed or follow us on LinkedIn.
###
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org.
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.
END
Nuclear medicine treatment cures lethal form of ovarian cancer in preclinical setting
2023-09-18
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Gene links exercise endurance, cold tolerance, and cellular maintenance in flies
2023-09-18
EMBARGOED FOR RELEASE UNTIL September 18, 2023 at 3:00 PM U.S. Eastern time
As the days get shorter and chillier in the northern hemisphere, those who choose to work out in the mornings might find it harder to get up and running. A new study in PNAS identifies a protein that, when missing, makes exercising in the cold that much harder—that is, at least in fruit flies.
A team from University of Michigan Medical School and Wayne State University School of Medicine discovered the protein in flies, which they named Iditarod after the famous long distance dog sled across Alaska, while studying metabolism and the effect of stress on the body.
They were particularly ...
Eureka baby! Groundbreaking study uncovers origin of ‘conscious awareness’
2023-09-18
Living things act with purpose. But where does purpose come from? How do humans make sense of their relation to the world and realize their ability to effect change? These fundamental questions of agency – acting with purpose – have perplexed some of the greatest minds in history including Sir Isaac Newton, Charles Darwin, Erwin Schrödinger and Niels Bohr.
A Florida Atlantic University study reveals groundbreaking insight into the origins of agency using an unusual and largely untapped source – human babies. Since goal-directed action appears in the first months ...
Study finds human-driven mass extinction is eliminating entire branches of the tree of life
2023-09-18
The passenger pigeon. The Tasmanian tiger. The Baiji, or Yangtze river dolphin. These rank among the best-known recent victims of what many scientists have declared the sixth mass extinction, as human actions are wiping out vertebrate animal species hundreds of times faster than they would otherwise disappear.
Yet, a recent analysis from Stanford University and the National Autonomous University of Mexico, published this week in the Proceedings of the National Academy of Sciences, shows the crisis may run even deeper. Each of the three species above was also the ...
An implantable device could enable injection-free control of diabetes
2023-09-18
CAMBRIDGE, MA -- One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections. However, one major obstacle to this approach is that once the cells are implanted, they eventually run out of oxygen and stop producing insulin.
To overcome that hurdle, MIT engineers have designed a new implantable device that not only carries hundreds of thousands of insulin-producing islet cells, but also has its own on-board oxygen factory, which generates oxygen by splitting water vapor found in the body.
The researchers showed that when ...
Buried ancient Roman glass formed substance with modern applications
2023-09-18
Some 2,000 years ago in ancient Rome, glass vessels carrying wine or water, or perhaps an exotic perfumes, tumble from a table in a marketplace, and shatter to pieces on the street. As centuries passed, the fragments were covered by layers of dust and soil and exposed to a continuous cycle of changes in temperature, moisture, and surrounding minerals.
Now these tiny pieces of glass are being uncovered from construction sites and archaeological digs and reveal themselves to be something extraordinary. On their surface is a mosaic of iridescent colors of blue, green and orange, with some displaying shimmering gold-colored ...
Genomes of enigmatic tusk shells provide new insights into early Molluscan evolution
2023-09-18
Accurate phylogenetic trees are fundamental to evolutionary and comparative biology, but the almost simultaneous emergence of major animal phyla and diverse body plans during the Cambrian Explosion poses major challenges to reconstructing deep metazoan phylogenetic relationships.
This is particularly true for the second largest phylum, Mollusca, whose major lineages originated in the Cambrian period. The diverse fossil record, extreme morphological disparity among the eight living classes, and dramatic conflict among phylogenetic hypotheses due to diverse paleontological, ...
Remote work can slash your carbon footprint — if done right
2023-09-18
ITHACA, N.Y. – Remote workers can have a 54% lower carbon footprint compared with onsite workers, according to a new study by Cornell University and Microsoft, with lifestyle choices and work arrangements playing an essential role in determining the environmental benefits of remote and hybrid work.
The study, published in the Proceedings of the National Academy of Sciences, also finds that hybrid workers who work from home two to four days per week can reduce their carbon footprint by 11% to 29%, but working from home one day per week ...
Preschoolers from low-income families may have worse health and benefit less from health promotion interventions than children with higher socioeconomic status
2023-09-18
Low socioeconomic status can negatively impact children’s health in preschool, along with their ability to follow specialized health education intervention programs, Mount Sinai researchers found in an international study focused on health promotion in schools, including those in the Harlem section of New York City. The results, published September 18 in the Journal of American College of Cardiology, stress the importance of introducing a specialized health curriculum in classrooms starting in preschool.
“This study shows that socioeconomic factors, including lower household income and education level, can negatively impact children’s health starting ...
Oregon State receives $7.5 million grant to build state of the art zebrafish biomedical research facility
2023-09-18
CORVALLIS, Ore. – Oregon State University has received a $7.5 million National Institutes of Health grant to modernize a lab focused on using zebrafish to address pressing human health challenges.
The Sinnhuber Aquatic Research Laboratory, led by Distinguished Professor Robyn Tanguay, a molecular toxicologist in the College of Agricultural Sciences, exploits the unique advantages of zebrafish to protect and improve human and environmental health. Zebrafish and humans have similar developmental processes and are similar on a genomic level, ...
Employee surveys may miss out on uncovering toxic leadership practices
2023-09-18
BINGHAMTON, N.Y. -- Standardized and overly simplistic questionnaires are only scratching the surface of what employees think of their leaders, according to new research from Binghamton University’s School of Management (SOM), and negative behavior may be slipping through the cracks.
As a result, the research finds, organizations may be missing out on critical information that could be keeping toxic leaders in positions of power.
“Instead of capturing actual leader behaviors, ratings might simply reflect whether a person likes their leader,” said Mengying ...